<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title42.html">
                                    Title 42
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/42CFR50.html">Part 50
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  50.504  Allowable cost of drugs.
                            </h3>
                            <p class="depth1"><em>(a)</em> The maximum amount which may be expended from program funds for  the acquisition of any drug shall be the lowest of</p><p class="depth2"><em>(1)</em> The maximum allowable cost (MAC) of the drug, if any,  established in accordance with 45 CFR part 19, plus a dispensing fee  determined by the Secretary in accordance with paragraph (b) of this  section, to be reasonable;</p><p class="depth2"><em>(2)</em> The acquisition cost of the drug plus a dispensing fee  determined by the Secretary, in accordance with paragraph (b) of this  section, to be reasonable; or</p><p class="depth2"><em>(3)</em> The provider's usual and customary charge to the public for the  drug; Provided, That the MAC established for any drug shall not apply to  a brand of that drug prescribed for a patient which the prescriber has  certified, in accordance with paragraph (c) of this section, is  medically necessary for that patient; And Provided further, That where  compensation for drug dispensing is included in other costs allowable  under the applicable program statute and regulations, the terms and  conditions of the grant or contract, and the applicable cost principles  prescribed in 45 CFR part 74, no separate dispensing fee will be  recognized.</p><p class="depth1"><em>(b)</em> In determining whether a dispensing fee is reasonable, the  Secretary will take into account:</p><p class="depth2"><em>(1)</em> Cost components such as overhead, professional services, and  profits,</p><p class="depth2"><em>(2)</em> Payment practices of third-party payment organizations,  including other Federal programs such as titles XVIII and XIX of the  Social Security Act; and</p><p class="depth2"><em>(3)</em> Any surveys by States, universities or others of costs of  pharmacy operations and the fees charged in the particular area.</p><p class="depth1"><em>(c)</em> A certification by a prescriber, pursuant to paragraph (a) of  this section, that a brand of drug is medically necessary for a  particular patient shall be in the prescriber's own handwriting, in such  form and manner as the Secretary may prescribe. An example of an  acceptable certification is the notation ``brand necessary''. A  procedure for checking a box on a form will not constitute an acceptable  certification.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
